Prelacrimal recess approach for maxillary sinus inverted papilloma: a 15-year experience from a single center
European Archives of Oto-Rhino-Laryngology · 2024
DOI: 10.1007/s00405-024-08551-x ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Na Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Papilloma, Inverted, Maxillary Sinus Neoplasms, Endoscopy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: The Capital Health Research and Development of Special, National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: This large retrospective, single-center, follow-up study investigated the endoscopic prelacrimal recess approach (PLRA) for treating maxillary sinus inverted papilloma (MSIP). METHODS: Between January 2007 and November 2022, patients with MSIP treated with PLRA were enrolled. Data on clinical manifestations, imaging, and surgical procedures were collected. The visual analog scale (VAS) scores for maxillofacial numbness and nasal symptoms and the SNOT-22 nasal symptom scores were statistically analyzed. RESULT: Of 122 patients (68 males and 54 females) enrolled in the study, with a mean age of 50.75 ± 12.84 years (26-80 years), 111 patients underwent PLRA, nine underwent modified PLRA, one converted to an endoscopic medial maxillectomy (EMM), and one to an endoscopic modified Denker's approach. The average follow-up was 86.60 (13-192) months, the recurrence rate was 3.28%, and 29 patients (23.77%) complained of maxillofacial numbness one month postoperatively, which disappeared in most cases one year after surgery. Five patients (4.10%) experienced mild numbness at the end of the follow-up period. Maxillary sinus ostium contracture or atresia occurred in two cases (1.64%). After surgery, the VAS nasal symptom scores improved significantly (P < 0.001). SNOT-22 indicated that the most common postoperative symptom was thick nasal discharge. CONCLUSION: PLRA is a flexible first-choice surgical treatment for maxillary sinus inverted papilloma and can be modified according to the extent of the lesion, the surgeon's experience and technique, and surgical instruments. That can help achieve complete resection and reduce recurrence and surgical complications. Upper teeth numbness, the most common postoperative complication, tends to disappear after 1 year.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Department of Otolaryngology, Beijing Huaxin Hospital, The First Affiliated Hospital of Tsinghua University, Beijing, China.
- Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. entzhou@263.net.
Förderung
- The Capital Health Research and Development of Special
- National Natural Science Foundation of China
Zitieren
APA
Liang, N., Qu, J., Huang, Q., & Zhou, B. (2024). Prelacrimal recess approach for maxillary sinus inverted papilloma: a 15-year experience from a single center. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08551-x
Vancouver
Liang N, Qu J, Huang Q, Zhou B. Prelacrimal recess approach for maxillary sinus inverted papilloma: a 15-year experience from a single center. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08551-x
BibTeX
@article{Liang2024,
author = {Liang, Na and Qu, Jing and Huang, Qian and Zhou, Bing},
title = {Prelacrimal recess approach for maxillary sinus inverted papilloma: a 15-year experience from a single center},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
doi = {10.1007/s00405-024-08551-x}
}
EUVIMED